Wells Fargo & Company Treace Medical Concepts, Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 19,215 shares of TMCI stock, worth $102,415. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,215
Previous 15,624
22.98%
Holding current value
$102,415
Previous $203,000
37.44%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding TMCI
# of Institutions
129Shares Held
39.5MCall Options Held
272KPut Options Held
261K-
Armistice Capital, LLC New York, NY5.36MShares$28.6 Million0.46% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$21.7 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL3.68MShares$19.6 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.62MShares$19.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.83MShares$15.1 Million0.0% of portfolio
About TREACE MEDICAL CONCEPTS, INC.
- Ticker TMCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 55,403,300
- Market Cap $295M
- Description
- Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...